Bacterial meningitis in a high HIV prevalence setting in sub-Saharan Africa--challenges to a better outcome.
Bacterial meningitis remains an important cause of mortality and morbidity worldwide. Approaches to reducing the incidence include the deployment of effective anti-retroviral therapy in areas where HIV co-infection is common, vaccination, and prophylactic antibiotic therapy. Health education, improved diagnostic speed and capacity, and ensuring appropriate antibiotic therapy may improve outcome amongst patients presenting with bacterial meningitis.
Scarborough
Matthew
M
University of Malawi College of Medicine, P Bag 360, Blantyre, Malawi.
Njalale
Yasin
Y
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology*; D017954:Africa South of the Sahara / Q000453:epidemiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D015658:HIV Infections / Q000150:complications / Q000453:epidemiology*; D006801:Humans; D016920:Meningitis, Bacterial / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology*; D015995:Prevalence
D000900:Anti-Bacterial Agents